BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company that plans to change its name to BeOne Medicines Ltd., has announced a settlement agreement with MSN Pharmaceuticals, Inc. and MSN Laboratories Private Ltd. to resolve patent litigation…
UCB and Biogen have unveiled detailed Phase 3 results for dapirolizumab pegol (DZP), a novel Fc-free anti-CD40L drug candidate, demonstrating significant improvements in managing moderate-to-severe systemic lupus erythematosus (SLE). Findings from the PHOENYCS GO study were presented as a late-breaking…
CVS Health® (NYSE: CVS) announced the addition of four new members to its Board of Directors: Leslie Norwalk, Larry Robbins, Guy Sansone, and Doug Shulman. These appointments follow collaborative discussions with Glenview Capital Management. “Our discussions with Glenview have reinforced…
Hansoh Pharmaceutical Group Co., Ltd. (03692.HK) announced that the U.S. FDA has granted Breakthrough Therapy Designation (BTD) to Inebilizumab for the treatment of Immunoglobulin G4-related disease (IgG4-RD). This designation follows positive results from the Global Phase 3 MITIGATE study, which…
A team of Nigerian researchers and clinicians, led by Aminu Kano Teaching Hospital, has made significant progress in understanding maternal and newborn health through a groundbreaking data initiative. In collaboration with the World Health Organization, the Nigerian Federal Ministry of…
Alnylam Pharmaceuticals (Nasdaq: ALNY) presented encouraging Phase 1 results for nucresiran (formerly ALN-TTRsc04), a next-generation RNAi therapeutic for transthyretin (ATTR) amyloidosis, at the American Heart Association Scientific Sessions 2024 in Chicago. The data revealed that a single dose of nucresiran…
Greywolf Therapeutics, a clinical-stage biotech company advancing novel antigen modulation technology that controls T cells to guide the immune system, has appointed Darlene Deptula-Hicks as Chief Financial Officer. An accomplished biotech and healthcare executive, Ms. Deptula-Hicks most recently served as…
Lumicell, Inc., a privately held company focused on developing innovative fluorescence-guided imaging technologies for cancerous tissue detection during surgery, is proud to announce the appointment of Howard Hechler as Chief Executive Officer. The Board of Directors is highly confident in…
Enveda, a biotechnology company using AI to translate nature into new medicines, announced today that the U.S. Food and Drug Administration (FDA) has cleared an investigational new drug (IND) application for its first asset targeting atopic dermatitis and other inflammatory…
Kanvas Biosciences, a spatial biology company, has unveiled clinical trial results at the 2024 Society for Immunotherapy of Cancer (SITC) meeting, showing the potential of fecal microbiota transplantation (FMT) in combination with anti-PD-1 re-induction to treat patients with microsatellite instability-high…
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced that it will present new data on a range of B-cell malignancies and treatments at the 66th ASH Annual Meeting in San Diego, December 7-10. The…
Moderna announced that Health Canada has approved mRESVIA™ (Respiratory Syncytial Virus mRNA vaccine) for the prevention of lower respiratory tract disease caused by RSV in adults aged 60 and older. “This approval demonstrates how our mRNA platform can tackle significant…